568 related articles for article (PubMed ID: 33351042)
1. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
[TBL] [Abstract][Full Text] [Related]
2. A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.
Kotecha D; Calvert M; Deeks JJ; Griffith M; Kirchhof P; Lip GY; Mehta S; Slinn G; Stanbury M; Steeds RP; Townend JN
BMJ Open; 2017 Jul; 7(7):e015099. PubMed ID: 28729311
[TBL] [Abstract][Full Text] [Related]
3. In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.
Karimzad K; Deswal A
Ann Intern Med; 2021 Jun; 174(6):JC69. PubMed ID: 34058112
[TBL] [Abstract][Full Text] [Related]
4. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
5. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
[TBL] [Abstract][Full Text] [Related]
6. Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation.
Garg J; Gopinathannair R; Lakkireddy D
JAMA; 2021 Apr; 325(16):1680-1681. PubMed ID: 33904875
[No Abstract] [Full Text] [Related]
7. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
[TBL] [Abstract][Full Text] [Related]
8. Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.
Parkash R; Wells GA; Rouleau J; Talajic M; Essebag V; Skanes A; Wilton SB; Verma A; Healey JS; Sterns L; Bennett M; Roux JF; Rivard L; Leong-Sit P; Jensen-Urstad M; Jolly U; Philippon F; Sapp JL; Tang ASL
Circulation; 2022 Jun; 145(23):1693-1704. PubMed ID: 35313733
[TBL] [Abstract][Full Text] [Related]
9. Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial.
Infeld M; Wahlberg K; Cicero J; Plante TB; Meagher S; Novelli A; Habel N; Krishnan AM; Silverman DN; LeWinter MM; Lustgarten DL; Meyer M
JAMA Cardiol; 2023 Mar; 8(3):213-221. PubMed ID: 36723919
[TBL] [Abstract][Full Text] [Related]
10. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
[TBL] [Abstract][Full Text] [Related]
11. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Stankovic I; Neskovic AN; Putnikovic B; Apostolovic S; Lainscak M; Edelmann F; Doehner W; Gelbrich G; Inkrot S; Rau T; Herrmann-Lingen C; Anker SD; Düngen HD
Int J Cardiol; 2012 Nov; 161(3):160-5. PubMed ID: 22726401
[TBL] [Abstract][Full Text] [Related]
12. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
Yamashita T; Inoue H
J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
[TBL] [Abstract][Full Text] [Related]
14. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
15. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
17. Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation-Reply.
Kotecha D
JAMA; 2021 Apr; 325(16):1681-1682. PubMed ID: 33904873
[No Abstract] [Full Text] [Related]
18. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
[TBL] [Abstract][Full Text] [Related]
19. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
20. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
